TC
CRDL

TownSquare Capital’s Cardiol Therapeutics CRDL Stock Holding History

TownSquare Capital’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,745
Closed -$27.2K – 1588
2024
Q3 		$27.2K Buy
+13,745
New +$28.5K ﹤0.01% 1476
2024
Q2 		– Sell
-12,661
Closed -$22.9K – 1311
2024
Q1 		$22.9K Buy
+12,661
New +$17.1K ﹤0.01% 1219

Other funds holding CRDL

TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
LSA
Lion Street Advisors Austin, Texas $289M AUM 3.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $8.94B AUM 20.84% 1-Year Est. Return

TownSquare Capital's CRDL Position: Q4 2024 in Review

TownSquare Capital sold out of Cardiol Therapeutics (CRDL) in Q4 2024, closing a stake of 13,745 shares — an estimated $27.2K sold.

TownSquare Capital first reported a position in CRDL in Q1 2024 and held it in 2 quarters. The position peaked at $27.2K in Q3 2024. 43 funds tracked by Wall St. Rank hold CRDL as of Q4 2024.

  • TownSquare Capital reported no remaining Cardiol Therapeutics position as of Q4 2024 after selling out during the quarter.
  • TownSquare Capital sold 13,745 Cardiol Therapeutics shares in Q4 2024, an estimated $27.2K.
  • TownSquare Capital first reported a position in Cardiol Therapeutics in Q1 2024 and held it in 2 quarters.
  • TownSquare Capital's Cardiol Therapeutics position peaked at $27.2K in Q3 2024.
  • 43 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q4 2024.

Based on TownSquare Capital's 13F filing for Q4 2024, filed 13 Feb 2025.